RENOVORX
RenovoRx is a developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents, to selected sites in the peripheral vascular system. RenovoRx received FDA clearance for the RenovoCath™ RC120 and is currently introducing this innovative technology to the clinical market. RenovoRx has a motivated Management Team with broad experience and an exciting vision for the future of targeted delivery. The company also has a broad Advisory Board of intervention... al radiologists, surgical oncologists and gastroenterologists that guide the company's clinical development strategies. RenovoRx is backed by a strong Board of Directors committed to long-term, continuous support of the company, whose members provide critical expertise in the medical and biotechnology industry and the visionary thinking to succeed.
RENOVORX
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2009-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.renovorx.com
Total Employee:
1+
Status:
Active
Contact:
650-284-4433
Email Addresses:
[email protected]
Total Funding:
10.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Boston Scientific
Boston Scientific investment in Series D - RenovoRx
Astia Angels
Astia Angels investment in Series D - RenovoRx
btov Partners
btov Partners investment in Series D - RenovoRx
Golden Seeds
Golden Seeds investment in Series D - RenovoRx
Portfolia
Portfolia investment in Series A - RenovoRx
Barbara Clarke
Barbara Clarke investment in Series A - RenovoRx
Plug and Play
Plug and Play investment in Series C - RenovoRx
Next Wave/Portfolia Angel Fund
Next Wave/Portfolia Angel Fund investment in Series C - RenovoRx
Golden Seeds
Golden Seeds investment in Series C - RenovoRx
Astia Angels
Astia Angels investment in Series C - RenovoRx
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-19 | RenovoRx Appoints James Ahlers as Chief Financial Officer |
Official Site Inspections
http://www.renovorx.com Semrush global rank: 4.7 M Semrush visits lastest month: 2.05 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RenovoRx"
About Us - RenovoRx
RenovoRx is a life sciences company developing novel targeted oncology therapies based on a local drug-delivery platform for high unmet medical need with a goal to improve therapeutic …See details»
RenovoRx – Developing Innovative Solutions for Targeted Delivery
RenovoRx is a life science company developing novel targeted oncology therapies based on a local drug-delivery platform for high unmet medical need with a goal to improve therapeutic …See details»
Company Information :: RenovoRX, Inc. (RNXT)
RenovoRx is a clinical-stage biopharmaceutical company with a vision to disrupt the current paradigm of cancer treatment. The company’s mission is to lead a revolution in oncology …See details»
RenovoRX, Inc. (RNXT)
Sep 25, 2024 · RenovoRx is a clinical-stage biopharmaceutical company with a vision to disrupt the current paradigm of cancer treatment. The company’s mission is to lead a revolution in …See details»
RenovoRx - Crunchbase Company Profile & Funding
RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system. View contacts for RenovoRx to access new leads and connect …See details»
RenovoRx (Nasdaq: RNXT) - LinkedIn
RenovoRx (Nasdaq: RNXT) is a life sciences company developing novel precision oncology therapies based on a local drug delivery platform for high unmet medical need with a goal to improve...See details»
Leadership Team - RenovoRx
RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system safely.See details»
RenovoRx, Inc. (RNXT) Company Profile & Overview - Stock Analysis
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients …See details»
RenovoRx CEO Issues Update Letter to Shareholders - Yahoo Finance
May 30, 2024 · BUSINESS WIRE. LOS ALTOS, Calif., May 30, 2024--RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a clinical-stage biopharmaceutical company …See details»
RenovoRx CEO Issues Letter to Shareholders
Feb 6, 2024 · (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local …See details»
Investor Relations - RenovoRx
Jul 13, 2022 · RenovoRx, a biopharmaceutical company headquartered in Silicon Valley, California, has developed a novel therapy platform, RenovoRx Trans-Arterial Micro-Perfusion …See details»
RenovoRx, Inc. (RNXT) Latest Stock News & Headlines - Yahoo …
LOS ALTOS, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel …See details»
RenovoRx Receives New 510(k) Clearance for its RenovoCath® …
Sep 7, 2021 · RenovoRx, a biopharmaceutical company headquartered in Silicon Valley, California, has developed a therapy platform targeting difficult-to-treat tumors. Targeted …See details»
RenovoRx Announces First Patient Enrolled at University of …
LOS ALTOS, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel …See details»
RenovoRx Increases Production of FDA-Cleared RenovoCath® …
Sep 25, 2024 · RenovoRx today announced that it is increasing the production of its FDA-cleared RenovoCath catheter-based delivery system due to increased demand for targeted delivery of …See details»
RenovoRx Company Profile - Office Locations, Competitors ... - Craft
Jul 31, 2024 · RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors. It offers a therapy platform, RenovoRx Trans …See details»
RNXT Stock Price Quote - Morningstar
Aug 27, 2021 · RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve …See details»
RenovoRx Reports Full Year 2022 Financial Results and …
Mar 2, 2023 · RenovoRx is a clinical-stage biopharmaceutical company with a vision to disrupt the current paradigm of cancer treatment. Our mission is to lead a revolution in oncology therapy …See details»
News - RenovoRx
Jun 21, 2022 · RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of difficult-to-treat solid tumors through its proprietary RenovoRx Trans …See details»
Who Owns RenovoRx – CBM - canvasbusinessmodel.com
Oct 19, 2024 · RenovoRx is a company that is dedicated to developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system. The ownership of …See details»